FIELD: the method of obtaining maleate.
SUBSTANCE: method is carried out by obtaining a suspension or solution of the compound represented by formula A and a suspension or solution of maleic acid in a solvent selected from a group consisting of ethanol, acetone, diethyl ether, water, ethyl acetate, 1,4-dioxane or a mixture thereof, respectively, by mixing a suspension or solution of the compound represented by formula A and maleic acid acids in a molar ratio of 1:1.0-1:2.6 to carry out the reaction; in this case, the reaction is carried out at 10-40°C with stirring, for 10-24 hours. Then the solvent is removed after the reaction is completed; and drying is performed at 10-40°C, for 1-24 hours, and the ratio of the mass of the compound represented by formula A to the volume of the solvent in this method is 4 mg:1 ml - 26 mg:1 ml.
EFFECT: production of 1–{2-fluoro-4-[5-(4-isobutylphenyl)-1,2,4-oxadiazole-3-yl]benzyl}-3-azetidine carboxylic acid maleate, characterized by significantly improved solubility in water and better bioavailability.
4 cl, 12 dwg, 7 tabl, 36 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A DERIVATIVE OF 7H-PYRROLO[2,3-D] PYRIMIDINE AND ITS INTERMEDIATE | 2016 |
|
RU2755618C2 |
POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR | 2008 |
|
RU2533830C2 |
SALT OF CONDENSED HETEROCYCLIC DERIVATIVE AND ITS CRYSTALS | 2011 |
|
RU2557237C2 |
N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(2-METHYLPROPYLOXY)PHENYLMETHYL) CARBAMIDE SALTS AND PREPARATION OF SAID SALTS | 2005 |
|
RU2387643C2 |
SALTS OF A QUINAZOLINE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2720810C2 |
BENZIMIDAZOLYLPYRIDYL ESTER SALTS AND COMPOSITIONS CONTAINING THEM | 2007 |
|
RU2457206C2 |
LIDINE-1-YL-ACETYLAMINO)-3-PHENYLPROPIONIC ACID ETHYL ESTER SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2174119C2 |
NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID | 2011 |
|
RU2612556C2 |
SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR ITS CRYSTALLINE FORM, PHARMACEUTICAL COMPOSITION AND FLT3 INHIBITOR | 2014 |
|
RU2641106C2 |
SOLID FORMS OF CEFTOLOZANE | 2014 |
|
RU2703457C2 |
Authors
Dates
2024-07-03—Published
2018-05-04—Filed